Chemotherapy consisting of paclitaxel and carboplatin benefits a patient with malignant mixed müllerian tumor of the fallopian tube

Wakae Kawaguchi, Hiroaki Itamochi, Junzo Kigawa, Yasunobu Kanamori, Tetsuro Oishi, Muneaki Shimada, Shinya Sato, Seiya Sato, Naoki Terakawa

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Malignant mixed müllerian tumors (MMMT) of the fallopian tube are extremely rare, and optimal therapy for them is unknown. A 71-year-old woman presented to us with symptoms of abdominal distension and nausea. A right salpingo-oophorectomy was performed. Pathological examination determined International Federation of Gynecology and Obstetrics (FIGO) stage IIIc MMMT of the right fallopian tube. Of note, multiple tumoral nodules were attached to the sigmoid colon. The patient received three courses of chemotherapy, consisting of 175 mg/m2 paclitaxel and AUC = 5 carboplatin (TC therapy), administered at 3-week intervals. A second, debulking, surgery was then performed, consisting of total abdominal hysterectomy, left salpingo- oophorectomy, and pelvic and paraaortic lymphadenectomy. The tumor attached to the sigmoid colon had shrunk by 60% after chemotherapy. The patient received an additional five courses of adjuvant TC therapy. The patient is alive and free of disease 28 months after the debulking surgery. TC therapy may be effective for MMMT of the fallopian tube.

Original languageEnglish
Pages (from-to)461-463
Number of pages3
JournalInternational Journal of Clinical Oncology
Volume13
Issue number5
DOIs
Publication statusPublished - 2008 Oct 1
Externally publishedYes

Keywords

  • Carboplatin
  • Chemoresponse
  • Fallopian tube
  • Malignant mixed müllerian tumor
  • Paclitaxel

ASJC Scopus subject areas

  • Surgery
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Chemotherapy consisting of paclitaxel and carboplatin benefits a patient with malignant mixed müllerian tumor of the fallopian tube'. Together they form a unique fingerprint.

  • Cite this